| Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa, ... MBio 12 (1), 10.1128/mbio. 03647-20, 2021 | 244 | 2021 |
| Development of vaccines for SARS-CoV-2 WH Ng, X Liu, S Mahalingam F1000Research 9, F1000 Faculty Rev-991, 2020 | 76 | 2020 |
| Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. MBio. 2021; 12 (1): e03647-20 WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa PMID 33563817, 03647-20, 2021 | 27 | 2021 |
| Comorbidities in SARS-CoV-2 patients: A systematic review and meta-analysis. mBio, 12 (1), e03647-20 WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa, ... | 22 | 2021 |
| Ocular tropism of SARS-CoV-2 in animal models with retinal inflammation via neuronal invasion following intranasal inoculation GU Jeong, HJ Kwon, WH Ng, X Liu, HW Moon, GY Yoon, HJ Shin, IC Lee, ... Nature Communications 13 (1), 7675, 2022 | 21 | 2022 |
| The Delta SARS-CoV-2 variant of concern induces distinct pathogenic patterns of respiratory disease in K18-hACE2 transgenic mice compared to the ancestral strain from Wuhan X Liu, H Mostafavi, WH Ng, JR Freitas, NJC King, A Zaid, A Taylor, ... MBio 13 (3), e00683-22, 2022 | 20 | 2022 |
| Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic? PCH Tang, WH Ng, NJC King, S Mahalingam PLoS pathogens 18 (9), e1010821, 2022 | 12 | 2022 |
| FHL1 promotes chikungunya and o’nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design WH Ng, X Liu, ZL Ling, CNO Santos, LS Magalhães, AJ Kueh, MJ Herold, ... Nature Communications 14 (1), 6605, 2023 | 11 | 2023 |
| Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9; 12 (1): e03647-20. doi: 10.1128/mBio. 03647-20 WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa, ... PMID, 0 | 10 | |
| Repurposing of drugs targeting the cytokine storm induced by SARS‐CoV‐2 WH Ng, PCH Tang, S Mahalingam, X Liu British Journal of Pharmacology 180 (2), 133-143, 2023 | 8 | 2023 |
| Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. mBio. 2021 Feb 9; 12 (1): e03647-20 WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa, ... DOI 10, 03647-20, 0 | 6 | |
| Chronic chikungunya disease (CCD): clinical insights, immunopathogenesis and therapeutic perspectives WH Ng, K Amaral, E Javelle, S Mahalingam QJM: An International Journal of Medicine 117 (7), 489-494, 2024 | 5 | 2024 |
| Role of MXRA8 in Ross river virus disease pathogenesis WH Ng, ZL Ling, AJ Kueh, MJ Herold, NP West, NJC King, S Mahalingam, ... Mbio 14 (2), e00588-23, 2023 | 3 | 2023 |
| TIR-domain-containing adapter-inducing interferon-β (TRIF)-dependent antiviral responses protect mice against Ross River virus disease X Liu, A Taylor, YS Poo, WH Ng, LJ Herrero, PCH Tang, A Zaid, ... MBio 13 (1), e03363-21, 2022 | 2 | 2022 |
| Cracking the code: ET-1 signaling unlocks new therapies for virus-induced osteoarthritis WH Ng, PCH Tang, S Mahalingam npj Viruses 2 (1), 50, 2024 | | 2024 |
| A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants X Liu, WH Ng, E Zusinaite, J Freitas, A Taylor, V Yerragunta, SM Aavula, ... Nature Communications 15 (1), 7225, 2024 | | 2024 |
| The role of host factors MXRA8 and FHL1 in arthritogenic alphavirus disease WH Ng | | 2024 |
